icone plus
Contact
Abonnez-vous aux actualités
Continuité d'Autorisation d’accès précoce octroyée à la spécialité SCEMBLIX (asciminib).
See also
Décision d'accès précoce
22/04/2022
Décision d'accès précoce
01/12/2022
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
XatAuFhKeUz7HRee